Foukas Joshua 4

What Happened

• Joshua Foukas, Chief Legal Officer of USANA Health Sciences (USNA), converted/exercised 6,577 restricted stock units (derivative conversion) on 2026-02-27. To cover tax withholding, 2,786 of those shares were surrendered/disposed at $21.52 per share, generating $59,955. Net shares retained from the conversion: 3,791. The exercise/conversion shows an effective exercise price of $0.00, consistent with RSUs rather than options.

Key Details

• Transaction date: 2026-02-27 (Report filed 2026-03-03; not marked late).
• Conversion: 6,577 shares (transaction code M — exercise/conversion of derivative).
• Tax withholding: 2,786 shares disposed at $21.52 each for $59,955 (transaction code F).
• Net shares received: 3,791 (6,577 − 2,786).
• Footnotes: F1 — each restricted stock unit (RSU) equals one share; F2 — RSUs vest 25% on the anniversary of Feb 27, 2025.
• No cash outlay for exercise (exercise price reported $0.00), indicating RSU settlement; sale of shares was solely to satisfy tax obligations, not an open‑market sell.

Context

• This is a routine settlement of vested RSUs, not a market purchase; tax‑withholding sales are common and do not necessarily signal insider sentiment. The filing shows conversion and withholding rather than a discretionary sale for cash.